Clinical Trial: Sentinel Node Biopsy Following NeoAdjuvant Chemotherapy in Biopsy Proven Node Positive Breast Cancer (SN-FNAC) ...
Sentinel Node Biopsy Following NeoAdjuvant Chemotherapy in Biopsy Proven Node Positive Breast Cancer (SN-FNAC) ... Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers. *Common Oncologic Emergencies That ... Clinical Trial: Sentinel Node Biopsy Following NeoAdjuvant Chemotherapy in Biopsy Proven Node Positive Breast Cancer (SN-FNAC) ... Clinical Trial: Sentinel Node Biopsy Following NeoAdjuvant Chemotherapy in Biopsy Proven Node Positive Breast Cancer (SN-FNAC) ...http://www.oncologynurseadvisor.com/breast-cancer-clinical-trials/clinical-trial-sentinel-node-biopsy-following-neoadjuvant-chemotherapy-in-biopsy-proven-node-positive-breast-cancer-sn-fnac/article/175699/
Perioperative Therapy for Resectable Pancreatic Cancer - Full Text View - ClinicalTrials.gov
A Phase II Study Induction Chemotherapy, Neoadjuvant Chemoradiotherapy, Surgical Resection and Adjuvant Chemotherapy for ... ADJUVANT CHEMOTHERAPY: Beginning 4-10 weeks after surgery, patients receive gemcitabine hydrochloride IV over 30 minutes and ... the end of adjuvant chemotherapy) ]. *Percent of Patients Surviving at Annual Intervals [ Time Frame: 5 years ]. ... Drugs used in chemotherapy, such as gemcitabine hydrochloride, docetaxel, capecitabine, and oxaliplatin, work in different ways ...https://clinicaltrials.gov/show/NCT00609336
Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian...
Patients who have received prior chemotherapy for any abdominal or pelvic tumor including neo-adjuvant chemotherapy for their ... Experimental: Arm I (adjuvant chemotherapy suboptimally debulked) Patients receive paclitaxel IV over 3 hours and carboplatin ... ARM I (adjuvant chemotherapy suboptimally debulked): Patients receive paclitaxel intravenously (IV) over 3 hours and ... patients receiving adjuvant or neoadjuvant chemotherapy are eligible for ACRIN 6695; the following sentence does not apply to ...https://clinicaltrials.gov/ct2/show/record/NCT01167712?show_desc=Y
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian,...
I. To determine if treatment with combination paclitaxel and carboplatin (TC) chemotherapy does not result in an inferior death ... Patients may have received prior adjuvant external beam radiation therapy and/or vaginal brachytherapy; patients should be at ... I. To determine if treatment with combination paclitaxel and carboplatin (TC) chemotherapy does not result in an inferior ... A Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Ifosfamide Plus Paclitaxel in Chemotherapy-Naive Patients ...https://clinicaltrials.gov/ct2/show/record/NCT00954174
Weekly Paclitaxel Plus Carboplatin in Preoperative Treatment of Breast Cancer - Full Text View - ClinicalTrials.gov
Preoperative chemotherapy for treatment of locally advanced breast cancer has become a standard therapy. Results from ... Paclitaxel was introduced into clinical practice in the early 1990s and has demonstrated good activity in the adjuvant and ... Willing to take biopsy before neoadjuvant chemotherapy and patients must be accessible for treatment and follow-up ... Weekly paclitaxel plus carboplatin is an effective nonanthracycline-containing regimen as neoadjuvant chemotherapy for breast ...https://clinicaltrials.gov/ct2/show/NCT01203267
Clinical Trial: Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable Non-Small Cell Lung Cancer ...
Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers. *Common Oncologic Emergencies That ... Daily online exclusives cover late breaking oncology news, safe handling and administration of chemotherapy drugs, side effect ...http://www.oncologynurseadvisor.com/lung-cancer-clinical-trials/clinical-trial-phase-iii-study-of-fractionated-stereotactic-radiotherapy-for-medically-inoperable-non-small-cell-lung-cancer-nsclc-or-metastatic-lung-tumours/article/207563/
Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer - Full Text View -...
ARTemis - Avastin Randomized Trial With Neo-Adjuvant Chemotherapy for Patients With Early Breast Cancer. ... Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer. The safety and ... Must be fit to receive chemotherapy on this trial, in the opinion of the responsible clinician, as indicated by the following ... It is not yet known whether giving combination chemotherapy together with or without bevacizumab is more effective in treating ...https://clinicaltrials.gov/ct2/show/NCT01093235?recr=Open&cond=%22Inflammatory+Breast+Neoplasms%22&rank=18
Neoadjuvant and adjuvant chemotherapy in pancreatic cancer | SpringerLink
Pancreatic cancer Neoadjuvant chemotherapy Adjuvant chemotherapy Evidence-based medicine Transcriptomics Precision medicine ... Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120(8):899-903CrossRefGoogle Scholar ... Adjuvant chemotherapy with gemcitabine and capecitabine in unselected patients can double 5-year overall survival to around 30 ... The aim of this article was to summarize existing evidence on neoadjuvant and adjuvant chemotherapy in PDAC with a focus on ...https://link.springer.com/article/10.1007%2Fs00423-018-1724-8
Adjuvant chemotherapy improves survival in early-stage ovarian cancer
... information on adjuvant chemotherapy but do not address which patients can be spared unnecessary adjuvant chemotherapy. He ... either adjuvant chemotherapy immediately after surgery for early-stage ovarian cancer or no immediate adjuvant chemotherapy. ( ... observed benefit of adjuvant chemotherapy primarily in nonoptimally staged patients suggests a benefit of adjuvant chemotherapy ... optimal staging was not associated with any survival benefit in patients who received adjuvant chemotherapy. Adjuvant ...http://www.innovations-report.com/html/reports/medicine-health/report-15734.html
Psychoneuroimmunology-Based Stress Management during Adjuvant Chemotherapy for Early Breast Cancer
J. A. Broeckel, P. B. Jacobsen, L. Balducci, J. Horton, and G. H. Lyman, "Quality of life after adjuvant chemotherapy for ... Psychoneuroimmunology-Based Stress Management during Adjuvant Chemotherapy for Early Breast Cancer. Jo Lynne W. Robins,1 Nancy ... In a randomized trial of women with early stage breast cancer undergoing adjuvant chemotherapy, two stress management ... in comparison to a usual care control group among women receiving adjuvant chemotherapy for stages I-IIIA breast cancer. We ...https://www.hindawi.com/journals/ecam/2013/372908/
Adjuvant Chemotherapy | Breast Cancer Care | Mercy Health
What is adjuvant chemotherapy? Learn about this cancer treatment, including who may be a candidate and what to expect from the ... Adjuvant chemotherapy for breast cancer. Adjuvant chemotherapy is commonly used for breast cancer when:. *Cells have migrated ... What is adjuvant chemotherapy?. Adjuvant chemotherapy is a cancer treatment that combines different healing therapies to ... What types of cancer is adjuvant chemotherapy used for?. Adjuvant chemotherapy is mainly used for cancers in the following body ...https://www.mercy.com/health-care-services/cancer-care-oncology/specialties/breast-cancer-treatment/treatments/adjuvant-chemotherapy
Psychiatric morbidity and physical toxicity associated with adjuvant chemotherapy after mastectomy. | The BMJ
Psychiatric morbidity and physical toxicity associated with adjuvant chemotherapy after mastectomy. Br Med J 1980; 281 :1179 ... Psychiatric morbidity and physical toxicity associated with adjuvant chemotherapy after mastectomy.. Br Med J 1980; 281 doi: ...http://www.bmj.com/content/281/6249/1179
SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer - Full Text View - ClinicalTrials.gov
SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer. The safety and scientific validity of this study is the ... Phase I/II Study of Oral S-1 Plus f Oxaliplatin as an Adjuvant Chemotherapy After Curative Resection of Stage II-IV(M0) Gastric ... chemotherapy complete rate [ Time Frame: 6 months ]. percentage of patients who completed eight cycles of chemotherapy ... The purpose of this study is to assess the safety and efficacy of S-1 plus oxaliplatin combination chemotherapy based on the ...https://clinicaltrials.gov/ct2/show/NCT01542294
Cancer Treatment: Drugs During Adjuvant Chemotherapy May Not Work | Science 2.0
... known as adjuvant chemotherapy, may not be benefiting from these drugs. ... "Adjuvant chemotherapy is a well established, but ineffective treatment in ER+ breast cancer patients aged 40 years or less . ... Article: 'Efficacy of adjuvant chemotherapy according to hormone receptor status in young breast cancer patients', Jos A. van ... known as adjuvant chemotherapy, may not be benefiting from these drugs. This is especially true if their tumors respond to ...https://www.science20.com/news_account/cancer_treatment_drugs_during_adjuvant_chemotherapy_may_not_work
Medline ® Abstract for Reference 109 of 'Adjuvant chemotherapy for resected stage II colon cancer'
... phenotype to predict benefit from adjuvant chemotherapy of colon cancer by 5-fluorouracil and leucovorin (FL) alone or with ... CONCLUSION: Our observations indicate that MSI status and p53 expression may influence the impact of oxaliplatin on adjuvant ... A Cox proportional hazards model was specifically designed to evaluate the interaction between chemotherapy and these genetic ... while the interaction of MSI with chemotherapy could not be determined in the absence of relapse in the MSI group treated with ...http://www.uptodate.com/contents/adjuvant-chemotherapy-for-resected-stage-ii-colon-cancer/abstract/109
Medline ® Abstract for Reference 18 of 'Adjuvant chemotherapy for resected stage II colon cancer'
PURPOSE: Fluorouracil plus leucovorin (FU + LV) adjuvant chemotherapy reduced the risk of recurrence and death across all time ... Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database. ... PATIENTS AND METHODS: A total of 12,233 patients enrolled to the randomized trials C-07, C-08, N0147, MOSAIC (Adjuvant ... CONCLUSIONS: These analyses support the addition of oxaliplatin to fluoropyrimidine-based adjuvant therapy in patients with ...http://www.uptodate.com/contents/adjuvant-chemotherapy-for-resected-stage-ii-colon-cancer/abstract/18
Efficacy of concurrent chemoradiotherapy plus adjuvant chemotherapy on advanced cervical cancer.
Chemotherapy, Adjuvant. Cisplatin / adverse effects, therapeutic use. Diarrhea / chemically induced, etiology. Dose ... Ten days after radiation therapy, TP regimen was administered as adjuvant chemotherapy.. RESULTS: For the experimental and ... CONCLUSION: Concurrent chemoradiotherapy plus adjuvant chemotherapy for advanced cervical cancer can improve short-term and ... This study aimed to explore the efficacy of concurrent chemoradiotherapy plus adjuvant chemotherapy on and the treatment ...http://www.biomedsearch.com/nih/Efficacy-concurrent-chemoradiotherapy-plus-adjuvant/20979696.html
Adjuvant Chemotherapy Improves Survival in Pancreatic Cancer - The ASCO Post
Adjuvant Chemotherapy Improves Survival in Pancreatic Cancer. By Caroline Helwick. June 10, 2016. Advertisement ... An adjuvant chemotherapy regimen improved overall survival in early-stage pancreatic cancer patients, in the large phase III ... In response to questions about choosing neoadjuvant or adjuvant chemotherapy now, Dr. Neoptolemos stated that the benefit of ... For resected pancreatic cancer patients, adjuvant chemotherapy with gemcitabine plus capecitabine improved median overall ...https://ascopost.com/issues/june-10-2016/adjuvant-chemotherapy-improves-survival-in-pancreatic-cancer/
Elderly Colon Cancer Patients Benefit From Adjuvant Chemotherapy | Cancer Network | The Oncology Journal
... based chemotherapy after surgery can be given safely to selected elderly patients with stage II/III colon cancer, and these ... adjuvant chemo-therapy. Data from the National Cancer Institute's. Surveillance Epidemiology, and End Results Program (SEER) ... regimens after surgery with no adjuvant chemotherapy for patients with stage. II/III colon cancer. Five studies used 5-FU plus ... Reasons for withholding adjuvant chemotherapy from elderly patients may. include coexisting conditions, fear of toxicity, ...http://www.cancernetwork.com/articles/elderly-colon-cancer-patients-benefit-adjuvant-chemotherapy
A Feasibility Study of Oral Adjuvant Chemotherapy With S-1 - Full Text View - ClinicalTrials.gov
A Feasibility Study of Oral Adjuvant Chemotherapy With S-1. The safety and scientific validity of this study is the ... The investigators confirm the feasibility of 1-year administration of oral fluoropyrimidine S-1 as an adjuvant chemotherapy for ... A Feasibility Study of Adjuvant Chemotherapy With Oral Fluoropyrimidine S-1 for Non-small Cell Lung Cancer. ... Chemotherapy comprised eight courses (4-week administration, 2-week withdrawal; total 1 year) of S-1 at 80-120 mg/body/day ...https://clinicaltrials.gov/ct2/show/NCT01459185
Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer Patients - Full Text View - ClinicalTrials.gov
Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer Patients. The safety and scientific validity of this study is the ... Adjuvant chemotherapy is critical for improving efficacy further. Unfortunately, the optimal adjuvant regimen is not identified ... prior adjuvant chemotherapy that did not include taxanes and S-1;. *white blood count ≥ 3,500/mm3, absolute neutrophil count ≥ ... This trial is going to evaluate the efficacy and safety of two regimens of DX and XELOX as adjuvant chemotherapy for stage IIIb ...https://clinicaltrials.gov/ct2/show/NCT01618474
Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach - Full Text View - ClinicalTrials.gov
Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach Trial) Study Group. Randomized trial on adjuvant ... Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach (ITACA-S). This study has been completed. ... Open Label, Randomised, Multicenter Phase III Study of Adjuvant Chemotherapy in Radically Resected Adenocarcinoma of the ... After relapse further chemotherapy is left to the investigator's judgement. When the last patient is randomised, follow-up will ...https://clinicaltrials.gov/ct2/show/NCT01640782
Efficacy Study of Adjuvant Chemotherapy for Chinese Primary Breast Cancer Patients
FEC100 Followed by Docetaxel and EC90 Followed by Paclitaxel as Adjuvant Chemotherapy for Chinese Primary Breast Cancer ... FEC100 Followed by Docetaxel and EC90 Followed by Paclitaxel as Adjuvant Chemotherapy for Chinese Primary Breast Cancer ... 6. Any chemotherapy, hormonal therapy or radiotherapy before surgery;. 7. Previous cancer (excepted cutaneous baso-cellular ...http://www.knowcancer.com/cancer-trials/NCT01314833/
NRF2 Pathway Activation and Adjuvant Chemotherapy Benefit in Lung Squamous Cell Carcinoma. | Sigma-Aldrich
NRF2 Pathway Activation and Adjuvant Chemotherapy Benefit in Lung Squamous Cell Carcinoma.. [David W Cescon, Desmond She, ... However, improved survival with adjuvant chemotherapy in the JBR.10-randomized trial appears limited to patients with the WT ... the clinical relevance of these findings and assessed whether NRF2 activation predicts benefit from adjuvant chemotherapy in ... A gene expression signature of NRF2 pathway activation is associated with benefit from adjuvant cisplatin/vinorelbine in SCC. ...https://www.sigmaaldrich.com/catalog/papers/25739673
Survival Benefit with Immediate Adjuvant Chemotherapy in Invasive Bladder Cancer
... June 23, 2014. No Comments ... These patients may also receive adjuvant chemotherapy-additional treatment administered after cystectomy. The goal is to ... To determine if immediate adjuvant chemotherapy could improve survival over deferred treatment in patients with invasive ... Ongoing research is evaluating the benefits of beginning adjuvant chemotherapy immediately following cystectomy or waiting ...http://news.cancerconnect.com/survival-benefit-with-immediate-adjuvant-chemotherapy-in-invasive-bladder-cancer/